💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Dicerna Pharmaceuticals, Inc. (DRNA)
« Back to company indexDRNA Chatter Timeline
Stock Ticker for DRNA
Most Active Tweeters for DRNA
| User | Tweets |
|---|---|
| @mediasentiment | 4 |
| @invescent | 4 |
| @Tickeron | 4 |
| @FinancialAdvBot | 1 |
| @HenryEdmund5 | 1 |
Recent Tweets for DRNA
 |
@Tikenw1Tikenw Based on $DRNA's recent quarterly reports, its earnings accruals are greater than most firms in the industry. These… https://t.co/yhCzGYwBRM January 24th 2022, 3:01am |
 |
@invescent $DRNA Data indicates that the overall analyst sentiment for DRNA is bearish. Simplify the way you research stock… https://t.co/vCqNXznMNM January 22nd 2022, 10:01pm |
|
@invescent $DRNA Data indicates that the overall analyst sentiment for DRNA is bullish. Simplify the way you research stock… https://t.co/aA6AzraE6H January 22nd 2022, 3:01am |
 |
@HenryEdmund5 $drna Real price will come out soon; Follow price targets.... https://t.co/kRKh23di6H January 21st 2022, 5:01pm |
|
@invescent $DRNA Data indicates that the overall analyst sentiment for DRNA is bearish. Simplify the way you research stock… https://t.co/ywcaoeKkAE January 19th 2022, 9:01am |
 |
@mediasentiment $DRNA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 84 January 17th 2022, 10:01am |
 |
@Tickeron $DRNA in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on December 27, 2021. View od… https://t.co/YU3entXlBW January 17th 2022, 10:01am |
 |
@FinancialAdvBot Buy low sell high $DRNA ? https://t.co/Kqw9EGbOOK January 16th 2022, 8:01pm |
|
@invescent $DRNA Data indicates that the overall analyst sentiment for DRNA is neutral Simplify the way you research stocks… https://t.co/KTAvIxxk9a January 16th 2022, 7:01am |
|
@mediasentiment $DRNA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 248 January 16th 2022, 4:01am |
|
@Tickeron $DRNA in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on December 27, 20… https://t.co/x32SUGmEqh January 16th 2022, 4:01am |
|
@mediasentiment $DRNA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 835 January 14th 2022, 4:01am |
|
@Tickeron $DRNA in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on December 27, 2021. View od… https://t.co/LCfPqbpwd3 January 14th 2022, 4:01am |
|
@mediasentiment $DRNA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 844 January 12th 2022, 3:01am |
|
@Tickeron $DRNA in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on December 27, 20… https://t.co/EPjpBYuuOk January 12th 2022, 3:01am |
|
@dsrgvr $DRNA the discretionary accruals (the portion of accruals that are independent from a firm’s performance, size, etc… https://t.co/6oE2i72Hta January 11th 2022, 1:01pm |
|
@invescent $DRNA Data indicates that the overall analyst sentiment for DRNA is bullish. Simplify the way you research stock… https://t.co/HvMQNCeBgu January 11th 2022, 1:01pm |
 |
@humour_humourrr @lblegend33 Lol. Same account blocked me when I respectfully disagreed that $DRNA was undervalued in $20s ? January 11th 2022, 12:01am |
 |
@FlashAlert_me $DRNA [15s. delayed] filed form 15-12B on January 10, 16:59:18 https://t.co/Xg7Yk32Mt1 January 10th 2022, 10:01pm |
 |
@Gwendol11245811 $drna Real price will come out soon; Follow price targets..:, ?? https://t.co/nHGVW9MKHA January 10th 2022, 4:01pm |
|
@mediasentiment $DRNA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 309 January 10th 2022, 3:01am |
|
@Tickeron $DRNA in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on December 27, 20… https://t.co/WANLJ6FBdM January 10th 2022, 3:01am |
|
@invescent $DRNA Data indicates that the overall analyst sentiment for DRNA is neutral Simplify the way you research stocks… https://t.co/5px6FIUCa8 January 4th 2022, 9:01am |
 |
@newsfilterio Form EFFECT (notice of effectiveness) filed with the SEC $DRNA https://t.co/HLT9By3eFL January 4th 2022, 5:01am |
|
@newsfilterio Form EFFECT (notice of effectiveness) filed with the SEC $DRNA https://t.co/EAHMIHPJcf January 4th 2022, 5:01am |
|
@newsfilterio Form EFFECT (notice of effectiveness) filed with the SEC $DRNA https://t.co/ZBBzVJ0NkY January 4th 2022, 5:01am |
|
@newsfilterio Form EFFECT (notice of effectiveness) filed with the SEC $DRNA https://t.co/lhQTtD8o0c January 4th 2022, 5:01am |
|
@FlashAlert_me $DRNA [15s. delayed] filed form EFFECT on January 03, 00:15:22 https://t.co/o8y8VQMOZn January 3rd 2022, 11:01am |
|
@FlashAlert_me $DRNA [15s. delayed] filed form EFFECT on January 03, 00:15:18 https://t.co/pszOlUFzdj January 3rd 2022, 11:01am |
|
@FlashAlert_me $DRNA [15s. delayed] filed form EFFECT on January 03, 00:15:26 https://t.co/zNQQT2lmGn January 3rd 2022, 11:01am |
|
@invescent $DRNA Data indicates that the overall analyst sentiment for DRNA is neutral Simplify the way you research stocks… https://t.co/OXrIYNDU31 January 3rd 2022, 4:01am |
 |
@ChartMill Besides having an excellent technical rating, $DRNA also presents a decent setup pattern. https://t.co/GHkOpmmKtU https://t.co/NpddCvXKct January 3rd 2022, 1:01am |
 |
@gmt9992 @pawcio2009 No one had picked $DRNA? January 1st 2022, 10:01pm |
 |
@7investing As there is no longer an opportunity for stock price gains regarding $DRNA, we decided to release Maxx's report fro… https://t.co/OArwNSE8MO December 31st 2021, 5:12pm |
 |
@shortablestocks Zero shares available to short currently in $DRNA. https://t.co/7YggzyRtv4 https://t.co/vgSkrpTTIS December 31st 2021, 4:12pm |
|
@shortablestocks Zero shares available to short currently in $DRNA. https://t.co/7YggzyRtv4 https://t.co/lKnOAd2iGA December 30th 2021, 4:12pm |
|
@Tickeron $DRNA in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators:… https://t.co/GrHF3rMlqN December 30th 2021, 2:12pm |
 |
@InsiderAlerts4U $DRNA: New Insider Filing on Dicerna Pharmaceuticals Inc's Director ADAM KOPPEL: https://t.co/mqHpi0yPn8 December 30th 2021, 2:12am |
|
@InsiderAlerts4U $DRNA: New Insider Filing on Dicerna Pharmaceuticals Inc's Chief Executive Officer DOUGLAS FAMBROUGH: https://t.co/5Pe4FmYz8y December 30th 2021, 1:12am |
|
@InsiderAlerts4U $DRNA: New Insider Filing on Dicerna Pharmaceuticals Inc's Chief Financial Officer DOUGLAS W. PAGAN: https://t.co/oeWc73ixxq December 30th 2021, 1:12am |
|
@InsiderAlerts4U $DRNA: New Insider Filing on Dicerna Pharmaceuticals Inc's Director CYNTHIA SMITH: https://t.co/zwHzRQIQ9W December 30th 2021, 1:12am |
|
@InsiderAlerts4U $DRNA: New Insider Filing on Dicerna Pharmaceuticals Inc's Director J KEVIN BUCHI: https://t.co/Uonc8yhhQR December 30th 2021, 12:12am |
|
@newsfilterio $178,474.50 of shares sold by Buchi J Kevin (Director), reported in a new form 4 filed with the SEC $DRNA https://t.co/x6UG2EAxXb December 30th 2021, 12:12am |
|
@newsfilterio $127,487.25 of shares sold by Doberstein Stephen K (Director), reported in a new form 4 filed with the SEC $DRNA https://t.co/vScdMdLe8x December 30th 2021, 12:12am |
|
@newsfilterio $127,487.25 of shares sold by Freed Martin I (Director), reported in a new form 4 filed with the SEC $DRNA https://t.co/K5q4NSywEQ December 30th 2021, 12:12am |
|
@newsfilterio $127,487.25 of shares sold by Gray Patrick M. (Director), reported in a new form 4 filed with the SEC $DRNA https://t.co/lRta4CreHa December 30th 2021, 12:12am |
|
@newsfilterio $618,005.25 of shares sold by Hoffman Stephen J (Director), reported in a new form 4 filed with the SEC $DRNA https://t.co/BCDXQxEfiB December 30th 2021, 12:12am |
|
@newsfilterio $433,487.25 of shares sold by Kozin Marc D (Director), reported in a new form 4 filed with the SEC $DRNA https://t.co/eF3y6FJ54W December 30th 2021, 12:12am |
|
@newsfilterio $127,487.25 of shares sold by Smith Cynthia (Director), reported in a new form 4 filed with the SEC $DRNA https://t.co/0KScoqwaV8 December 29th 2021, 11:12pm |
|
@InsiderAlerts4U $DRNA: New Insider Filing on Dicerna Pharmaceuticals Inc's Director STEPHEN J HOFFMAN: https://t.co/tEF3trpQAF December 29th 2021, 11:12pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?